Recalls & Warnings July 30, 2003 Maker of Weight-Loss and Cellulite Treatment Ordered to Stop False Claims and Pay Consumer Redress On July 30, 2003 the Federal Trade Commission (FTC) reported that a Canadian-based company operating in the United States under the name Bio Lab, and its president, Jean-Francois Brochu, have agreed to settle FTC charges that they deceived consumers through false and unsubstantiated advertising
serum BUN was determined using the Bioassay systems assay (DIUR-100) according to the manufacturers directions
Mitigates the damage from cortisol injections, which negatively impacts muscles and soft tissue
The problem is, most people cant keep up with demand
Treatment may involve oral high-dose B12 tablets or intramuscular hydroxocobalamin injections , depending on the underlying cause (see the following section for dosing detail)
Shipping: Fast Sydney/Melbourne Dispatch via Australia Post Express What Is BPC-157